Researchers at Rutgers Ernest Mario School of Pharmacy have shown that administering a combination of the widely used drugs Celebrex (celecoxib, a nonsteroidal anti-inflammatory drug) and Lipitor (atorvastatin, a cholesterol ...read News
The study findings, published in a recent issue of Urologic Nursing, underscore the need for health-care practitioners to educate their patients about the physical and psychological effects the surgery will ...read News
In the early view version of The Journal of Urology, Dr. Crook and colleagues present a single practitioner series of 125I prostate brachytherapy with analysis of long-term sequelae.
Australian scientists are researching a possible way of making aggressive prostate cancer cells less invasive after their discovery of a protein essential for the normal functioning of cells.
This is a large case-control study estimating prostate cancer incidence among users of statins and other cholesterol-lowering drugs in a study population of 24,723 case-control pairs. It is a register-based ...read News
In the September issue of the Journal of Clinical Oncology, Dr. Northouse and researchers report on the psychosocial effects of prostate cancer (CaP) across the spectrum of the illness.
According to a report in the early view section of the Journal of Urology by Dr. Shah and CaPSURE investigators, increasing number of prostate biopsy cores may have contributed indirectly ...read News
The part of the prostate that is biopsied may matter more than the number of biopsy samples taken for accurately diagnosing prostate cancer, according to a study by researchers at ...read News
In the November 2007 issue of the Journal of the National Cancer Institute, Dr. Thall and colleagues report on changing chemotherapy regimens based upon patient response and provide statistical modeling ...read News
home
login
search
